Skip to main content

Home/ Medicine & Healthcare/ Group items matching "topical" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
avivajazz  jazzaviva

Nonsurgical Treatment Options for Basal Cell Carcinoma | Review Article | Journal of Skin Cancer | 2011 - 0 views

  •  
    Journal of Skin CancerVolume 2011 (2011), Article ID 571734, 6 pagesdoi:10.1155/2011/571734 © 2011 Mary H. Lien and Vernon K. Sondak.
avivajazz  jazzaviva

Efficacy of topical 5% imiquimod cream for the tre... [Arch Dermatol. 2002] - PubMed result - 0 views

  •  
    Topical 5% imiquimod cream is well tolerated and most effective in treating nodular BCC when applied once daily for 7 days per week for either 12 or 6 weeks.
avivajazz  jazzaviva

Aldara ~ Prior Authorization Guideline - 0 views

  •  
    Superficial Basal Cell Carcinoma Aldara™ cream is indicated for the topical treatment of biopsy-confirmed, primary superficial basal cell carcinoma (sBCC) in immunocompetent adults, with a maximum tumor diameter of 2.0 cm, located on the trunk (excluding anogenital skin), neck, extremities (excluding hands and feet), only when surgical methods are medically less appropriate and patient follow-up can be reasonably assured.  The histological diagnosis of superficial basal cell carcinoma should be established for other types of basal cell carcinomas, including nodular, morpheaform (fibrosing or sclerosing) types.
avivajazz  jazzaviva

Mohs Surgery Animation Handout - Doctor recommended review - 0 views

  •  
    Mohs surgery technique is is typically reserved for skin cancers that have a high risk of reappearing or for skin cancers that have recurred. Mohs surgery is also a preferred option for removing skin cancer from areas such as the face
avivajazz  jazzaviva

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream | Alessi SS, et al | CLINICS 2009;64(10):961-6 - 0 views

    • avivajazz  jazzaviva
       
      For patients without comorbidities, our study revealed good cure rates for superficial BCC and superficial/nodular BCC (88% and 85%, respectively). Nodular and aggressive BCC and Bowen's disease exhibited lower cure rates (50%, 50%, and 57%, respectively). I
  •  
    For patients without comorbidities, our study revealed good cure rates for superficial BCC and superficial/nodular BCC (88% and 85%, respectively). Nodular and aggressive BCC and Bowen's disease exhibited lower cure rates (50%, 50%, and 57%, respectively). I
avivajazz  jazzaviva

Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series. [J Eur Acad Dermatol Venereol. 2009] - PubMed - 0 views

  •  
    Clinical clearance rate at 1 and 2 years were 89% and 85%, respectively.
avivajazz  jazzaviva

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream - 0 views

  •  
    For patients without comorbidities, our study revealed good cure rates for superficial BCC and superficial/nodular BCC (88% and 85%, respectively). Nodular and aggressive BCC and Bowen's disease exhibited lower cure rates (50%, 50%, and 57%, respectively). I
avivajazz  jazzaviva

Treatment of cutaneous tumors with topical 5% imiq... [Clinics (Sao Paulo). 2009] - PubMed result - 0 views

  •  
    For patients without comorbidities, the overall cure rate was 73%. For these patients, the cure rates were 85.7% for superficial and nodular BCC, 88% for superficial BCC, 57% for Bowen's disease, 50% for nodular BCC, and 50% for aggressive BCC.
1 - 20 of 35 Next ›
Showing 20 items per page